Adaptive Biotechnologies Corp (NASDAQ: ADPT) on Monday, soared 3.57% from the previous trading day, before settling in for the closing price of $10.09. Within the past 52 weeks, ADPT’s price has moved between $2.99 and $10.37.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 16.04%. The company achieved an average annual earnings per share of 21.49%. With a float of $144.91 million, this company’s outstanding shares have now reached $151.92 million.
Considering the fact that the conglomerate employs 619 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 61.06%, operating margin of -71.5%, and the pretax margin is -74.86%.
Adaptive Biotechnologies Corp (ADPT) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Adaptive Biotechnologies Corp is 4.61%, while institutional ownership is 95.10%. The most recent insider transaction that took place on May 16 ’25, was worth 17,149. In this transaction Chief Financial Officer of this company sold 1,929 shares at a rate of $8.89, taking the stock ownership to the 277,396 shares. Before that another transaction happened on May 01 ’25, when Company’s Chief Scientific Officer sold 68,412 for $7.35, making the entire transaction worth $502,828. This insider now owns 1,279,524 shares in total.
Adaptive Biotechnologies Corp (ADPT) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 21.49% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.19% during the next five years compared to -1.51% drop over the previous five years of trading.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Trading Performance Indicators
Adaptive Biotechnologies Corp (ADPT) is currently performing well based on its current performance indicators. A quick ratio of 2.82 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.96, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.65 in one year’s time.
Technical Analysis of Adaptive Biotechnologies Corp (ADPT)
Compared to the last year’s volume of 1.99 million, its volume of 1.26 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 82.57%. Additionally, its Average True Range was 0.55.
During the past 100 days, Adaptive Biotechnologies Corp’s (ADPT) raw stochastic average was set at 96.00%, which indicates a significant increase from 91.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.45% in the past 14 days, which was lower than the 83.60% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.53, while its 200-day Moving Average is $6.76.
